To Investigate the Prevalence of Children Asthma in China
1 other identifier
observational
20,000
0 countries
N/A
Brief Summary
Asthma is the most common chronic respiratory disease in children and has much effect on their life and study, which leads to huge economic burden and pressure to the whole families. Some children will develop into adult patients so that asthma can be the life-long vigorous trouble. In recent years, the prevalence rate of children asthma is increasingly going up worldwide. The prevalence rate in last 12 months reported in USA, United Kingdom, Australia, New Zealand was between 12% to 30%. Center for Asthma Prevention and Education of Capital Institute of Pediatrics investigated the national asthma prevalence in 900 thousands children in 27 provinces and cities, which average rate was 0.11% to 2.03% in 1990. In 2000, we investigated it again in 31 provinces(43 cities) and the average national children asthma prevalence rate was 1.97%(0.25% to 4.63%) which was much higher than that in 1990.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2011
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 17, 2011
CompletedFirst Posted
Study publicly available on registry
March 21, 2011
CompletedStudy Start
First participant enrolled
April 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedAugust 4, 2014
August 1, 2014
2 years
March 17, 2011
August 1, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
prevalence of asthma
Apr 2013
Secondary Outcomes (1)
prevalence of allergic rhinitis
Apr 2013
Study Arms (2)
Asthma children
children with asthma symptoms through screening
normal children
children without symptoms of asthma
Eligibility Criteria
children age from 0 to 14 years in big cities in China
You may qualify if:
- children age from 0 to 14 years
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Capital Institute of Pediatrics, Chinalead
- Merck Sharp & Dohme LLCcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
YuZhi Chen, professor
Capital Institute of Pediatrics, China
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 17, 2011
First Posted
March 21, 2011
Study Start
April 1, 2011
Primary Completion
April 1, 2013
Study Completion
April 1, 2014
Last Updated
August 4, 2014
Record last verified: 2014-08